The identification of common genetic, molecular, and cellular pathogenic mechanisms in diabetes and rheumatoid arthritis may shed new light in the development of a metabolic disease during a chronic inflammatory process and may identify new specific targets to derive a precision medicine driven therapeutic strategy
26 Settembre 2023
Development of a systemic sclerosis skin tissue model via 3D bioprinting for investigating novel potential therapeutic treatments
26 Settembre 2023
Evaluation of the possible role of Upadacitinib in Neuro-Immune axis regulation of pain mediators
26 Settembre 2023
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platinum Maintenance Therapy for Participants With Recurrent, Platinum-Sensitive, Ovarian Cancer (UP-NEXT)
26 Settembre 2023
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (UP-LIFT)
26 Settembre 2023
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
26 Settembre 2023
A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma (FLORA-5)
26 Settembre 2023
